JCM | Free Full-Text | Lymphopenia as a Predictor for Adverse Clinical Outcomes in
Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases …

Background: Lymphopenia is one of features that helps identify patients with severe Covid-
19. This retrospectively study analyzed the association of lymphopenia with the severity of …

Background. Coronavirus disease 2019 (COVID-19) has a high mortality in certain group of
patients. We analysed the impact of baseline immunosuppression in COVID-19 mortality …

Results On admission, 84 (43.8%) patients suffered from lymphopenia among COVID-19
patients. The count and percentage of lymphocytes on admission were lower among …

Objective Clinical and laboratory biomarkers to predict the severity of coronavirus disease
2019 (COVID-19) are essential in this pandemic situation of which resource allocation must …

Abstract Objectives Coronavirus Disease 2019 (COVID-19) is a new respiratory and
systemic disease which needs quick identification of potential critical patients. This meta …

The outbreak of SARS-CoV-2 began in December 2019 and rapidly became a pandemic.
The present study investigated the significance of lymphopenia on disease severity. A total …

Simple Summary The coronavirus disease 2019 (COVID-19) pandemic caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a major global …

Objective: To detect association of lymphopenia with disease severity and mortality.
Methods: Total 874 COVID RT-PCR positive patients admitted to KRL Hospital Islamabad …

Background: There is a compelling need to identify clinical and laboratory predictors of
unfavorable clinical course and death in patients with coronavirus disease (COVID-19). A …